These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20432391)

  • 21. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Coherex FlatStent: an advance in patent foramen ovale closure.
    Ruygrok PN
    Expert Rev Med Devices; 2010 Mar; 7(2):193-9. PubMed ID: 20214425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
    Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double BioDisk: a new bioprosthetic device for transcatheter closure of atrial septal defects - a feasibility study in adult sheep.
    Pavcnik D; Tekulve K; Uchida BT; Luo ZH; Jeromel M; Van Alstine WG; Keller FS; Rösch J
    Radiol Oncol; 2012 Jun; 46(2):89-96. PubMed ID: 23077444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
    Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The BioSTAR(r) device versus the CardioSEAL(r) device in patent foramen ovale closure: comparison of mid-term efficacy and safety.
    Van den Branden BJ; Luermans JG; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    EuroIntervention; 2010 Sep; 6(4):498-504. PubMed ID: 20884438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interatrial shunt closure devices in patients with nickel allergy.
    Reddy BT; Patel JB; Powell DL; Michaels AD
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):647-51. PubMed ID: 19777603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous retrieval of the locked helex septal occluder.
    Poommipanit P; Levi D; Shenoda M; Tobis J
    Catheter Cardiovasc Interv; 2011 May; 77(6):892-900. PubMed ID: 20853357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience.
    Sievert H; Fischer E; Heinisch C; Majunke N; Roemer A; Wunderlich N
    Circulation; 2007 Oct; 116(15):1701-6. PubMed ID: 17893276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
    Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
    Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.
    Braun M; Gliech V; Boscheri A; Schoen S; Gahn G; Reichmann H; Haass M; Schraeder R; Strasser RH
    Eur Heart J; 2004 Mar; 25(5):424-30. PubMed ID: 15033255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up results of transcatheter occlusion of atrial septal defects with buttoned device.
    Rao PS; Ende DJ; Wilson AD; Smith PA; Chopra PS
    Can J Cardiol; 1995 Sep; 11(8):695-701. PubMed ID: 7671179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomy of the patent foramen ovale for the interventionalist.
    McKenzie JA; Edwards WD; Hagler DJ
    Catheter Cardiovasc Interv; 2009 May; 73(6):821-6. PubMed ID: 19330826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal healing patterns and coverage dynamics after new Polish transcatheter PFO occluder implantation in a swine.
    Milewski K; Fiszer R; Buszman PP; Węglarz P; Janas A; Krauze A; Jelonek M; Hirnle P; Smolka G; Gil R; Białkowski J; Buszman PE
    Kardiol Pol; 2017; 75(9):907-913. PubMed ID: 28612912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
    Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies.
    Wöhrle J; Kochs M; Spiess J; Nusser T; Hombach V; Merkle N
    Circulation; 2009 Jun; 119(23):3002-8. PubMed ID: 19487592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.